IBDEI03X ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4938,1,5,0)
 ;;=5^Primary Thrombocytopenia
 ;;^UTILITY(U,$J,358.3,4938,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,4939,0)
 ;;=288.09^^33^368^8
 ;;^UTILITY(U,$J,358.3,4939,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4939,1,4,0)
 ;;=4^288.09
 ;;^UTILITY(U,$J,358.3,4939,1,5,0)
 ;;=5^Agranulocytosis
 ;;^UTILITY(U,$J,358.3,4939,2)
 ;;=^334042
 ;;^UTILITY(U,$J,358.3,4940,0)
 ;;=284.81^^33^368^15
 ;;^UTILITY(U,$J,358.3,4940,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4940,1,4,0)
 ;;=4^284.81
 ;;^UTILITY(U,$J,358.3,4940,1,5,0)
 ;;=5^Aplastic Due To Drugs
 ;;^UTILITY(U,$J,358.3,4940,2)
 ;;=^335245
 ;;^UTILITY(U,$J,358.3,4941,0)
 ;;=284.89^^33^368^14
 ;;^UTILITY(U,$J,358.3,4941,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4941,1,4,0)
 ;;=4^284.89
 ;;^UTILITY(U,$J,358.3,4941,1,5,0)
 ;;=5^Aplastic Anemia due to Chr disease
 ;;^UTILITY(U,$J,358.3,4941,2)
 ;;=^87880
 ;;^UTILITY(U,$J,358.3,4942,0)
 ;;=284.9^^33^368^12
 ;;^UTILITY(U,$J,358.3,4942,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4942,1,4,0)
 ;;=4^284.9
 ;;^UTILITY(U,$J,358.3,4942,1,5,0)
 ;;=5^Aplastic Anemia NOS
 ;;^UTILITY(U,$J,358.3,4942,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,4943,0)
 ;;=289.84^^33^368^117
 ;;^UTILITY(U,$J,358.3,4943,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4943,1,4,0)
 ;;=4^289.84
 ;;^UTILITY(U,$J,358.3,4943,1,5,0)
 ;;=5^Thrombocytopenia,Heparin Induced
 ;;^UTILITY(U,$J,358.3,4943,2)
 ;;=^336542
 ;;^UTILITY(U,$J,358.3,4944,0)
 ;;=204.02^^33^368^3
 ;;^UTILITY(U,$J,358.3,4944,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4944,1,4,0)
 ;;=4^204.02
 ;;^UTILITY(U,$J,358.3,4944,1,5,0)
 ;;=5^ALL, In Relapse
 ;;^UTILITY(U,$J,358.3,4944,2)
 ;;=^336465
 ;;^UTILITY(U,$J,358.3,4945,0)
 ;;=204.12^^33^368^25
 ;;^UTILITY(U,$J,358.3,4945,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4945,1,4,0)
 ;;=4^204.12
 ;;^UTILITY(U,$J,358.3,4945,1,5,0)
 ;;=5^CLL in Remission
 ;;^UTILITY(U,$J,358.3,4945,2)
 ;;=^336466
 ;;^UTILITY(U,$J,358.3,4946,0)
 ;;=204.21^^33^368^112
 ;;^UTILITY(U,$J,358.3,4946,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4946,1,4,0)
 ;;=4^204.21
 ;;^UTILITY(U,$J,358.3,4946,1,5,0)
 ;;=5^Subacute LL in Remission
 ;;^UTILITY(U,$J,358.3,4946,2)
 ;;=^267526
 ;;^UTILITY(U,$J,358.3,4947,0)
 ;;=204.20^^33^368^113
 ;;^UTILITY(U,$J,358.3,4947,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4947,1,4,0)
 ;;=4^204.20
 ;;^UTILITY(U,$J,358.3,4947,1,5,0)
 ;;=5^Subacute LL w/o Remission
 ;;^UTILITY(U,$J,358.3,4947,2)
 ;;=^336852
 ;;^UTILITY(U,$J,358.3,4948,0)
 ;;=204.22^^33^368^114
 ;;^UTILITY(U,$J,358.3,4948,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4948,1,4,0)
 ;;=4^204.22
 ;;^UTILITY(U,$J,358.3,4948,1,5,0)
 ;;=5^Subacute LL, in Relapse
 ;;^UTILITY(U,$J,358.3,4948,2)
 ;;=^336467
 ;;^UTILITY(U,$J,358.3,4949,0)
 ;;=203.02^^33^368^100
 ;;^UTILITY(U,$J,358.3,4949,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4949,1,4,0)
 ;;=4^203.02
 ;;^UTILITY(U,$J,358.3,4949,1,5,0)
 ;;=5^Multiple Myeloma,In Relapse
 ;;^UTILITY(U,$J,358.3,4949,2)
 ;;=^336462
 ;;^UTILITY(U,$J,358.3,4950,0)
 ;;=205.02^^33^368^6
 ;;^UTILITY(U,$J,358.3,4950,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4950,1,4,0)
 ;;=4^205.02
 ;;^UTILITY(U,$J,358.3,4950,1,5,0)
 ;;=5^AML, In Relapse
 ;;^UTILITY(U,$J,358.3,4950,2)
 ;;=^336470
 ;;^UTILITY(U,$J,358.3,4951,0)
 ;;=205.12^^33^368^27
 ;;^UTILITY(U,$J,358.3,4951,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4951,1,4,0)
 ;;=4^205.12
 ;;^UTILITY(U,$J,358.3,4951,1,5,0)
 ;;=5^CML in Relapse
 ;;^UTILITY(U,$J,358.3,4951,2)
 ;;=^336471
 ;;^UTILITY(U,$J,358.3,4952,0)
 ;;=V10.91^^33^368^63
 ;;^UTILITY(U,$J,358.3,4952,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4952,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,4952,1,5,0)
 ;;=5^H/O Neuroendocrine CA Tumor
 ;;^UTILITY(U,$J,358.3,4952,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,4953,0)
 ;;=V10.91^^33^368^72
 ;;^UTILITY(U,$J,358.3,4953,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4953,1,4,0)
 ;;=4^V10.91
 ;;^UTILITY(U,$J,358.3,4953,1,5,0)
 ;;=5^H/O Unspecified Malignant Neoplasm
 ;;^UTILITY(U,$J,358.3,4953,2)
 ;;=^338494
 ;;^UTILITY(U,$J,358.3,4954,0)
 ;;=465.9^^33^369^73
 ;;^UTILITY(U,$J,358.3,4954,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4954,1,4,0)
 ;;=4^465.9
 ;;^UTILITY(U,$J,358.3,4954,1,5,0)
 ;;=5^Uri
 ;;^UTILITY(U,$J,358.3,4954,2)
 ;;=URI^269878
 ;;^UTILITY(U,$J,358.3,4955,0)
 ;;=462.^^33^369^60
 ;;^UTILITY(U,$J,358.3,4955,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4955,1,4,0)
 ;;=4^462.
 ;;^UTILITY(U,$J,358.3,4955,1,5,0)
 ;;=5^Sore Throat
 ;;^UTILITY(U,$J,358.3,4955,2)
 ;;=^2653
 ;;^UTILITY(U,$J,358.3,4956,0)
 ;;=466.0^^33^369^3
 ;;^UTILITY(U,$J,358.3,4956,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4956,1,4,0)
 ;;=4^466.0
 ;;^UTILITY(U,$J,358.3,4956,1,5,0)
 ;;=5^Bronchitis,Acute
 ;;^UTILITY(U,$J,358.3,4956,2)
 ;;=^259084
 ;;^UTILITY(U,$J,358.3,4957,0)
 ;;=112.1^^33^369^78
 ;;^UTILITY(U,$J,358.3,4957,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4957,1,4,0)
 ;;=4^112.1
 ;;^UTILITY(U,$J,358.3,4957,1,5,0)
 ;;=5^Vulvovaginitis,Candidal
 ;;^UTILITY(U,$J,358.3,4957,2)
 ;;=^18615
 ;;^UTILITY(U,$J,358.3,4958,0)
 ;;=616.0^^33^369^13
 ;;^UTILITY(U,$J,358.3,4958,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4958,1,4,0)
 ;;=4^616.0
 ;;^UTILITY(U,$J,358.3,4958,1,5,0)
 ;;=5^Cervicitis
 ;;^UTILITY(U,$J,358.3,4958,2)
 ;;=^21925
 ;;^UTILITY(U,$J,358.3,4959,0)
 ;;=599.0^^33^369^74
 ;;^UTILITY(U,$J,358.3,4959,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4959,1,4,0)
 ;;=4^599.0
 ;;^UTILITY(U,$J,358.3,4959,1,5,0)
 ;;=5^UTI
 ;;^UTILITY(U,$J,358.3,4959,2)
 ;;=UTI^124436
 ;;^UTILITY(U,$J,358.3,4960,0)
 ;;=460.^^33^369^45
 ;;^UTILITY(U,$J,358.3,4960,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4960,1,4,0)
 ;;=4^460.
 ;;^UTILITY(U,$J,358.3,4960,1,5,0)
 ;;=5^Nasopharyngitis, Acute
 ;;^UTILITY(U,$J,358.3,4960,2)
 ;;=^26543
 ;;^UTILITY(U,$J,358.3,4961,0)
 ;;=372.30^^33^369^14
 ;;^UTILITY(U,$J,358.3,4961,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4961,1,4,0)
 ;;=4^372.30
 ;;^UTILITY(U,$J,358.3,4961,1,5,0)
 ;;=5^Conjunctivitis
 ;;^UTILITY(U,$J,358.3,4961,2)
 ;;=^27546
 ;;^UTILITY(U,$J,358.3,4962,0)
 ;;=595.9^^33^369^15
 ;;^UTILITY(U,$J,358.3,4962,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4962,1,4,0)
 ;;=4^595.9
 ;;^UTILITY(U,$J,358.3,4962,1,5,0)
 ;;=5^Cystitis
 ;;^UTILITY(U,$J,358.3,4962,2)
 ;;=^30304
 ;;^UTILITY(U,$J,358.3,4963,0)
 ;;=110.1^^33^369^16
 ;;^UTILITY(U,$J,358.3,4963,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4963,1,4,0)
 ;;=4^110.1
 ;;^UTILITY(U,$J,358.3,4963,1,5,0)
 ;;=5^Dermatophytosis Nail
 ;;^UTILITY(U,$J,358.3,4963,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,4964,0)
 ;;=562.11^^33^369^17
 ;;^UTILITY(U,$J,358.3,4964,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4964,1,4,0)
 ;;=4^562.11
 ;;^UTILITY(U,$J,358.3,4964,1,5,0)
 ;;=5^Diverticulitis
 ;;^UTILITY(U,$J,358.3,4964,2)
 ;;=^270274
 ;;^UTILITY(U,$J,358.3,4965,0)
 ;;=424.90^^33^369^18
 ;;^UTILITY(U,$J,358.3,4965,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4965,1,4,0)
 ;;=4^424.90
 ;;^UTILITY(U,$J,358.3,4965,1,5,0)
 ;;=5^Endocarditis
 ;;^UTILITY(U,$J,358.3,4965,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,4966,0)
 ;;=604.90^^33^369^19
 ;;^UTILITY(U,$J,358.3,4966,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4966,1,4,0)
 ;;=4^604.90
 ;;^UTILITY(U,$J,358.3,4966,1,5,0)
 ;;=5^Epididymitis
 ;;^UTILITY(U,$J,358.3,4966,2)
 ;;=^86178
 ;;^UTILITY(U,$J,358.3,4967,0)
 ;;=707.15^^33^369^21
 ;;^UTILITY(U,$J,358.3,4967,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4967,1,4,0)
 ;;=4^707.15
 ;;^UTILITY(U,$J,358.3,4967,1,5,0)
 ;;=5^Foot Ulcer
 ;;^UTILITY(U,$J,358.3,4967,2)
 ;;=^322148
 ;;^UTILITY(U,$J,358.3,4968,0)
 ;;=558.9^^33^369^22
 ;;^UTILITY(U,$J,358.3,4968,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4968,1,4,0)
 ;;=4^558.9
 ;;^UTILITY(U,$J,358.3,4968,1,5,0)
 ;;=5^Gastroenteritis
 ;;^UTILITY(U,$J,358.3,4968,2)
 ;;=^87311
 ;;^UTILITY(U,$J,358.3,4969,0)
 ;;=054.71^^33^369^33
 ;;^UTILITY(U,$J,358.3,4969,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4969,1,4,0)
 ;;=4^054.71
 ;;^UTILITY(U,$J,358.3,4969,1,5,0)
 ;;=5^Herpes Simplex, Mouth/Lip
 ;;^UTILITY(U,$J,358.3,4969,2)
 ;;=^266574
 ;;^UTILITY(U,$J,358.3,4970,0)
 ;;=054.10^^33^369^23
 ;;^UTILITY(U,$J,358.3,4970,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4970,1,4,0)
 ;;=4^054.10
 ;;^UTILITY(U,$J,358.3,4970,1,5,0)
 ;;=5^Genital Herpes, Unsp
 ;;^UTILITY(U,$J,358.3,4970,2)
 ;;=^56853
 ;;^UTILITY(U,$J,358.3,4971,0)
 ;;=098.0^^33^369^72
 ;;^UTILITY(U,$J,358.3,4971,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4971,1,4,0)
 ;;=4^098.0
 ;;^UTILITY(U,$J,358.3,4971,1,5,0)
 ;;=5^Urethritis,Gonococcal
 ;;^UTILITY(U,$J,358.3,4971,2)
 ;;=^52567
 ;;^UTILITY(U,$J,358.3,4972,0)
 ;;=054.13^^33^369^35
 ;;^UTILITY(U,$J,358.3,4972,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4972,1,4,0)
 ;;=4^054.13
 ;;^UTILITY(U,$J,358.3,4972,1,5,0)
 ;;=5^Herpetic Infect Of Penis
 ;;^UTILITY(U,$J,358.3,4972,2)
 ;;=^266560
 ;;^UTILITY(U,$J,358.3,4973,0)
 ;;=054.11^^33^369^36
 ;;^UTILITY(U,$J,358.3,4973,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4973,1,4,0)
 ;;=4^054.11
 ;;^UTILITY(U,$J,358.3,4973,1,5,0)
 ;;=5^Herpetic Vulvovaginitis
 ;;^UTILITY(U,$J,358.3,4973,2)
 ;;=^57012
 ;;^UTILITY(U,$J,358.3,4974,0)
 ;;=053.9^^33^369^34
 ;;^UTILITY(U,$J,358.3,4974,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4974,1,4,0)
 ;;=4^053.9
 ;;^UTILITY(U,$J,358.3,4974,1,5,0)
 ;;=5^Herpes Zoster Nos
 ;;^UTILITY(U,$J,358.3,4974,2)
 ;;=^56946
 ;;^UTILITY(U,$J,358.3,4975,0)
 ;;=487.1^^33^369^39
 ;;^UTILITY(U,$J,358.3,4975,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4975,1,4,0)
 ;;=4^487.1
 ;;^UTILITY(U,$J,358.3,4975,1,5,0)
 ;;=5^Influenza
 ;;^UTILITY(U,$J,358.3,4975,2)
 ;;=^63125
 ;;^UTILITY(U,$J,358.3,4976,0)
 ;;=487.0^^33^369^40
 ;;^UTILITY(U,$J,358.3,4976,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,4976,1,4,0)
 ;;=4^487.0
 ;;^UTILITY(U,$J,358.3,4976,1,5,0)
 ;;=5^Influenza W/ Pneumonia
 ;;^UTILITY(U,$J,358.3,4976,2)
 ;;=^269942
 ;;^UTILITY(U,$J,358.3,4977,0)
 ;;=386.30^^33^369^41
 ;;^UTILITY(U,$J,358.3,4977,1,0)
 ;;=^358.31IA^5^2
